Global Cancer Summit - 2020

On behalf of the organizing committee, we take this opportunity in extending a warm and cordial welcome to you to be a part of the Global Cancer Summit - 2020. Global Cancer Summit – 2020 conference is scheduled for 19th December 2020. This conference aim is to gather the most elegant societies and industries along with the renowned and honorable persons from top universities across the globe. The Global Cancer Summit – 2020 organizing committee is confident that participants will get benefits from this high-value scientific program.

Global cancer/tumor profiling market was valued at $13.30 billion in 2012. At the end of 2013, the market is estimated to be $14.99 billion and is poised to reach around $35 billion by 2018, growing at a CAGR of 18.50% from 2013 to 2018. Global oncology spending hit $91 billion for 2013 and it's growing at a 5% clip annually, which will cross $100 billion in 2015. The key players in cancer/tumor profiling market are Boreal Genomics Inc. (U.S.), Caris Life Sciences (U.S.), Genomic Health Inc. (U.S.), Illumina Inc. (U.S.), Life Technologies Corporation (U.S.), NeoGenomics Laboratories (U.S.), Oxford Gene Technology Ltd. (U.K.), Precision Therapeutics Inc. (U.S.), bioTheranostics (U.S.), Proteome Sciences PLC (U.K.), Agendia (The Netherlands), Nanostring Technologies (U.S.), Rational Therapeutics (U.S.), Oncopath Laboratories (U.S.), and RiboMed BiotechnologiesInc. (U.S.). The global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, growing at a CAGR of 12.9%. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The cancer diagnostics market in Asia is expected to grow at the highest rate from 2015 to 2020. According to the market, the global oncology drug market is expected to reach $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan, and Avastin, is expected to boost the growth of the cancer biosimilars market by 2020.

Global Cancer Summit - 2020 is a one-day event consisting of a lettered scientific program, laudable talks by the top-notch of the global scientific community, that brings together active researchers, intellectuals, academicians, students, contributors, and industrialists to exchange ideas communicate, and discuss research findings on new advancements in all kinds of available oncology and cancer research worldwide innovative research products which can be exhibited for further development in Oncology. This Global Cancer Summit – 2020 is going to be the largest and most promising international conference that specifically focuses on the Oncology, Radiation therapy by bringing all Renowned Oncologists under one roof. This will be the multidisciplinary meeting covering all aspects of Oncology, New Innovation, Cancer Drug Development, Cancer Therapies, and Radiation Oncology, including clinical service delivery, management, informatics, and research.

Similarly, the conference will show the students a new way for future innovations. The conference also focuses on current research evidence, practical experiences, and innovative ideas on issues related to Oncology and Cancer Research

The Global Cancer Summit - 2020 will also confer Edward Kennedy Memorial Award to the best presenter from the senior research category and the Asima Chatterjee Memorial awards to the best presenter from the Young Researchers. The Global Cancer Summit - 2020 will also recognised the best young innovators and will be conferred with Renato Dulbecco Memorial Award.

Looking forward to meeting you at the webinar this December.